ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

NAN Nanoscience

4.375
0.00 (0.00%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Nanoscience LSE:NAN London Ordinary Share KYG6390E1070 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.375 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Infineon Licensing Agreement

10/09/2008 7:01am

UK Regulatory


    Embargoed Release: 07:00hrs Wednesday 10th September 2008

                               Nanoscience Inc.                                

                        (`Nanoscience' or the `Group')                         

                 Toumaz Signs Licensing Agreementwith Infineon                 

Nanoscience, the specialist niche investor in emerging technologies with strong
commercial propositions for the healthcare and electronic sectors, is pleased
to announce that its wholly owned subsidiary Toumaz Technology Limited
(`Toumaz'), has concluded a new licensing agreement with Infineon Technologies
AG (`Infineon'), a global semiconductor and system solutions provider. Under
the agreement Infineon has the right to develop and market wireless silicon
chips based on Toumaz's ultra-low power semiconductor technology for
non-medical applications.

Toumaz's ultra-low power semiconductor technology was initially developed with
a particular focus on medical applications such as wireless infrastructure body
monitoring solutions. However, the evolved technology has universal
applicability for a wide range of non-medical applications seeking low power
wireless connectivity solutions using significantly (typically 10 times) less
power than currently available technology. This translates into longer
operating lifetimes, smaller batteries and form factors, and the possibility of
low cost autonomous wireless sensors using paper batteries, solar cells or
energy scavenging power systems.

The licensing agreement is a further extension of the relationship established
between Toumaz and Infineon in 2005 concerning first and second generation
ultra low power wireless silicon chip fabrication. The licensing agreement
includes payment of licensing fees and royalties by Infineon on the sale of
Toumaz's technology based on the cumulative number of products sold per annum.
The Group anticipates this agreement will further diversify and expand Toumaz's
product catalogue by the exploitation of its core IP and offer exciting new
channels to revenue growth. In addition, the agreement enhances Toumaz's
strategy of building global partnerships; Toumaz currently has active
agreements with Texas Instruments Incorporated and Cardinal Health Incorporated
within healthcare.

Professor Chris Toumazou, chairman and chief technology officer of Toumaz,
commented:

`This is a further endorsement of the low power technology that Toumaz has
spent considerable time developing. I am pleased that our investors will be
able to see returns not only from the very substantial medical opportunities
but also from wider non-medical applications'

Guy Spelman, chief executive officer of Nanoscience, commented:

`The signing of a licensing agreement with Infineon further cements the
tremendous prospects of Toumaz's ultra low power semiconductor technology. It
is highly encouraging to see that Toumaz's technology has the adaptability to
address numerous markets and to attract high calibre companies to license and
extend Toumaz's product reach on a global scale.'

                                    -Ends-                                     

Further information:

Guy Spelman Nanoscience Inc. 07767 338 967

Charles Cunningham/Rose Herbert FinnCap 020 7600 1658

Vikki Krause Hansard Group 020 7245 1100

www.hansardgroup.co.uk

About Toumaz Technology (www.toumaz.com) :


Toumaz Technology Limited is the leading provider of ultra-low power wireless
infrastructure for body monitoring solutions. Toumaz's ultra low-power smart
sensor interface and transceiver platform - the Sensium(tm) - enables
non-intrusive, real-time wireless monitoring of multiple vital signs for a wide
range of healthcare, sports and lifestyle management applications.

Based on Toumaz's patented ultra-low power Advanced Mixed Signal (AMx(tm))
technology, the Sensium(tm) provides the enabling technology to connect the mobile
individual to healthcare providers and sports trainers - simply, affordably and
unobtrusively.

About Infineon:

Infineon Technologies is a global business offering semiconductor and system
solutions addressing three central challenges to modern society: energy
efficiency, communications, and security.



END


1 Year Nanoscience Chart

1 Year Nanoscience Chart

1 Month Nanoscience Chart

1 Month Nanoscience Chart